Drug target and biomarker for multiple sclerosis

— Technology Description

Researchers in Prof. Robyn Klein’s laboratory have discovered that interferon lambda (IFN-λ) is a potential target for treating multiple sclerosis (MS), particularly secondary progressive MS (SPMS).

Most patients with MS present with relapsing remitting MS (RRM…

Controlling charge doping in 2D materials

— Technology Description

Researchers at Washington University in St. Louis have developed a method to control charge doping in 2D materials like graphene. This method uses α-RuCl3 to create pn junctions at a smaller scale than silicon transistors.

While α-RuCl3 efficiently removes el…

Create a Collection
Creating...